PL366579A1 - Leczenie infekcji paznokci za pomocą NO - Google Patents

Leczenie infekcji paznokci za pomocą NO

Info

Publication number
PL366579A1
PL366579A1 PL02366579A PL36657902A PL366579A1 PL 366579 A1 PL366579 A1 PL 366579A1 PL 02366579 A PL02366579 A PL 02366579A PL 36657902 A PL36657902 A PL 36657902A PL 366579 A1 PL366579 A1 PL 366579A1
Authority
PL
Poland
Prior art keywords
treatment
nitric oxide
nail infections
infections
relates
Prior art date
Application number
PL02366579A
Other languages
English (en)
Other versions
PL213555B1 (pl
Inventor
Nigel Benjamin
Original Assignee
Aberdeen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aberdeen University filed Critical Aberdeen University
Publication of PL366579A1 publication Critical patent/PL366579A1/pl
Publication of PL213555B1 publication Critical patent/PL213555B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Wynalazek dotyczy kompozycji generujących tlenek azotu, które są użyteczne w leczeniu infekcji podpaznokciowych, ponieważ tlenek azotu wykazuje właściwości przenikania przez paznokieć i wykazuje działanie przeciwgrzybicze. Wynalazek dotyczy także zestawów mających zastosowanie w wymienionym leczeniu oraz zastosowania kompozycji generujących tlenek azotu do wytwarzania lekarstwa do leczenia lub profilaktyki infekcji podpaznokciowych.
PL366579A 2001-08-03 2002-08-02 Zastosowanie azotynu i kwasu organicznego do wytwarzania leku do leczenia infekcji grzybiczych podpaznokciowych PL213555B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections

Publications (2)

Publication Number Publication Date
PL366579A1 true PL366579A1 (pl) 2005-02-07
PL213555B1 PL213555B1 (pl) 2013-03-29

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366579A PL213555B1 (pl) 2001-08-03 2002-08-02 Zastosowanie azotynu i kwasu organicznego do wytwarzania leku do leczenia infekcji grzybiczych podpaznokciowych

Country Status (23)

Country Link
US (2) US20050037093A1 (pl)
EP (1) EP1411908B1 (pl)
JP (1) JP2005501069A (pl)
KR (1) KR20040031780A (pl)
CN (1) CN1321633C (pl)
AT (1) ATE296094T1 (pl)
AU (1) AU2002318001B2 (pl)
BR (1) BR0211390A (pl)
CA (1) CA2453243C (pl)
DE (1) DE60204322T2 (pl)
ES (1) ES2242042T3 (pl)
GB (1) GB0119011D0 (pl)
HR (1) HRP20040059B1 (pl)
HU (1) HUP0401190A3 (pl)
IL (2) IL159724A0 (pl)
MX (1) MXPA04000670A (pl)
NO (1) NO20040258L (pl)
NZ (1) NZ530577A (pl)
PL (1) PL213555B1 (pl)
PT (1) PT1411908E (pl)
RU (1) RU2298403C2 (pl)
WO (1) WO2003013489A1 (pl)
ZA (1) ZA200400491B (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
AU2004257693B8 (en) 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
ES2326387T3 (es) 2005-03-24 2009-10-08 Nolabs Ab Tratamiento cosmetico con oxido nitrico, dispositivo para llevar a cabo dicho tratamiento y procedimiento de fabricacion del mismo.
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2006128121A2 (en) 2005-05-27 2006-11-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
JP5795165B2 (ja) 2007-11-15 2015-10-14 ルイジアナ ステイト ユニヴァーシティー 慢性虚血における亜硝酸塩の使用
WO2009086470A2 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
EP2334279A4 (en) * 2008-10-16 2013-03-20 Novan Inc STAIN OXIDE RELEASING PARTICLES FOR MOUTH CARE APPLICATIONS
WO2010048724A1 (en) * 2008-10-30 2010-05-06 Chris Miller Nitric oxide-releasing dressings
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
BR112012008508A2 (pt) * 2009-10-13 2017-06-13 Novan Inc revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
ES2633618T3 (es) * 2009-10-14 2017-09-22 Theravasc Inc. Formulaciones farmacéuticas de nitrito y sus usos
US20130089629A1 (en) * 2010-06-07 2013-04-11 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
EP2691087A2 (en) 2011-03-31 2014-02-05 László Gábor Szabó Pharmaceutical composition containing no, process for the preparation and use thereof
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
KR20160120785A (ko) 2011-08-17 2016-10-18 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경구 전달 시스템을 통해 생리학적 및 치료학적 수준의 일산화질소를 생산하는 방법
US11077194B2 (en) 2012-03-14 2021-08-03 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
AU2014218916A1 (en) 2013-02-20 2015-09-03 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US12233289B2 (en) 2013-08-01 2025-02-25 Olaplex, Inc. Methods for fixing hair and skin
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
WO2016022170A1 (en) 2014-08-08 2016-02-11 Novan, Inc. Topical emulsions
ES2964826T3 (es) * 2014-03-14 2024-04-09 Sanotize Res And Developmemt Corp Composiciones y métodos para tratar enfermedades o trastornos usando soluciones de liberación de óxido nítrico de liberación extendida
ES2824105T3 (es) 2014-05-16 2021-05-11 Olaplex Inc Formulaciones y métodos de tratamiento de queratina
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
KR102495101B1 (ko) 2014-07-11 2023-02-02 노반, 인크. 국소 항바이러스 조성물 및 그의 사용 방법
WO2016010988A1 (en) 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
EP3285733B1 (en) 2015-04-24 2019-10-23 Liqwd, Inc. Methods for treating relaxed hair
WO2017019614A1 (en) 2015-07-28 2017-02-02 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
WO2017180822A1 (en) 2016-04-13 2017-10-19 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
WO2018236803A1 (en) 2017-06-19 2018-12-27 Novan, Inc. Topical compositions and methods of using the same
CN112165935A (zh) 2018-03-01 2021-01-01 诺万公司 一氧化氮释放性栓剂及其使用方法
US11472705B2 (en) 2018-03-13 2022-10-18 Sanotize Research And Development Corp. Nitric oxide releasing compositions
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
JP7686578B2 (ja) 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
JP2023510661A (ja) * 2019-06-04 2023-03-15 サーティー ホールディングス リミテッド 窒素酸化物を生成するための方法及び組成物、並びにそれらの使用
US20230172973A1 (en) 2020-04-23 2023-06-08 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
BR112022021454A2 (pt) 2020-04-23 2023-01-31 Thirty Respiratory Ltd Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2
CA3186075A1 (en) * 2020-07-16 2022-01-20 Gilly REGEV Methods of treating conditions responsive to nitric oxide therapy
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
DE69532921T2 (de) * 1994-02-21 2005-04-14 Aberdeen University, Aberdeen Angesäuertes nitrit zur verwendung als antimikrobielles mittel
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
HRP20040059B1 (hr) 2008-05-31
CN1321633C (zh) 2007-06-20
MXPA04000670A (es) 2004-10-27
ZA200400491B (en) 2005-04-22
NZ530577A (en) 2007-01-26
RU2298403C2 (ru) 2007-05-10
HUP0401190A3 (en) 2008-08-28
CA2453243C (en) 2012-01-03
BR0211390A (pt) 2004-08-17
EP1411908A1 (en) 2004-04-28
RU2004101765A (ru) 2005-03-10
PT1411908E (pt) 2005-08-31
DE60204322D1 (de) 2005-06-30
AU2002318001B2 (en) 2007-02-15
ES2242042T3 (es) 2005-11-01
CN1564681A (zh) 2005-01-12
WO2003013489A1 (en) 2003-02-20
JP2005501069A (ja) 2005-01-13
EP1411908B1 (en) 2005-05-25
CA2453243A1 (en) 2003-02-20
IL159724A (en) 2006-04-10
DE60204322T2 (de) 2006-01-26
HUP0401190A2 (hu) 2004-11-29
PL213555B1 (pl) 2013-03-29
KR20040031780A (ko) 2004-04-13
US20100015253A1 (en) 2010-01-21
HRP20040059A2 (en) 2004-08-31
NO20040258L (no) 2004-03-29
IL159724A0 (en) 2004-06-20
GB0119011D0 (en) 2001-09-26
ATE296094T1 (de) 2005-06-15
US20050037093A1 (en) 2005-02-17
US9381381B2 (en) 2016-07-05

Similar Documents

Publication Publication Date Title
PL366579A1 (pl) Leczenie infekcji paznokci za pomocą NO
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
MY135721A (en) Amidino compounds useful as nitric oxide synthase inhibitors
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
MY144318A (en) Methods of treating hiv infection.
DE60312211D1 (de) Haarbehandlungsmittel
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
MXPA02002119A (es) Productos leguminosos.
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
DK1660100T3 (da) Anti-tumorformuleringer der omfatter defibrotid alene eller i kombination med andre anti-tumormidler
BR0111785A (pt) Composições e métodos para tratamento de candidìase
PL1737420T3 (pl) Kompozycje do traktowania włosów
ATE391489T1 (de) Haarbehandlungszusammensetzungen
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
MX2007007015A (es) Composiciones farmaceuticas para el tratamiento de celulitis.
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
ATE324450T1 (de) Polypeptid, das neutralisierende antikörper gegen hiv induziert
WO2000074667A3 (en) Compositions active in telomere damage comprising a taxane and telomerase inhibitor
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection
ATE390144T1 (de) Behandlung von fibrosen
PT1355650E (pt) Combinacao de ingredientes activos contendo alfuzosina e apomorfina
ECSP003530A (es) Derivados de indoloxoacetil piperazina antivirocos